Abstract
The use of reirradiation for recurrent pediatric brain tumors has been increasing, but the effect of repeat radiation on critical cranial structures is unknown. Between July 2009 and May 2013, the records of 12 pediatric patients initially treated with proton therapy and then with reirradiation for recurrent brain tumors were retrospectively reviewed for toxicity and outcomes. Initial and repeat radiation dose distributions were deformed and merged to determine the maximum dose to 0.03 cm3 of the optic chiasm, optic nerves, spinal cord, brainstem, cochleae, pituitary, and uninvolved brain, and to 1 cm3 of the brainstem and brain on individual and composite plans. These dosimetric results were compared with auditory, neurocognitive, ophthalmologic, and endocrine outcomes to identify radiation-associated toxicities. Median follow-up was 3.5 years from diagnosis. Median ages at initial and repeat radiation were 4.6 and 6.7 years, respectively. All patients initially received proton radiotherapy to a median tumor dose of 55.8 Gy relative biological effectiveness (RBE) (range, 45 to 60 Gy [RBE]). At progression, patients completed a second course of radiation to local fields (n = 7) or the craniospinal axis (n = 5) with a median tumor dose of 40 Gy (RBE) (range, 20 to 54 Gy [RBE]). Median progression-free survival was 22.7 months from the last day of the second radiation course. No patient developed central nervous system necrosis requiring treatment. Of evaluable patients, none developed radiation-related high-grade hearing loss (n = 11), visual pathway deficit (n = 10), or significant change in pre- and post-reirradiation full-scale intelligence quotient (n = 4). Of 11 evaluable patients, 4 (36.4%) developed secondary hypothyroidism and 1 (9.1%) developed growth hormone deficiency. Repeat radiation for recurrent brain tumors after proton therapy may be performed in the pediatric population with acceptable short- and long-term toxicity.
Highlights
Primary brain tumors in children recur in 20% to 70% of cases [1]
Reirradiation of pediatric brain tumors have typically used the prescribed dose to guide treatment planning, but modern conformal techniques allow for the avoidance of normal structures while providing therapeutic doses to target volumes
To explore our institutional outcomes with reirradiation, we retrospectively reviewed the clinical and dosimetric records of 12 pediatric patients initially treated with proton therapy who subsequently underwent a second course of radiation to the brain
Summary
Primary brain tumors in children recur in 20% to 70% of cases [1]. Survival after progression remains poor [2]; reirradiation is increasingly used and has shown promising results [1,2,3,4,5]. Risks of reirradiation include central nervous system (CNS) necrosis, cognitive decline, and cranial nerve impairment. The tolerance of critical structures within the cranium to repeat radiation is not well established. Reirradiation of pediatric brain tumors have typically used the prescribed dose to guide treatment planning, but modern conformal techniques allow for the avoidance of normal structures while providing therapeutic doses to target volumes. The dose to critical structures may be less than the prescribed dose
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
